Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous thiamine for acute kidney injury outcomes in sepsis: randomized controlled trial
TCTR20250526004Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine in sepsis, acute kidney failure (AKF), sponsored by Phramongkutklao Hospital. Started Jul 2024; status: completed.
02
Drugs
thiamine
03
Conditions
sepsisacute kidney failure (AKF)
Beyond the preview
Go deeper on TCTR20250526004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250526004.